New combo aims to outsmart resistant lung cancer
NCT ID NCT04467723
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding pirfenidone to the immunotherapy drug atezolizumab can help shrink tumors and prevent treatment resistance in people with advanced or returning non-small cell lung cancer. About 25 adults with stage IV or recurrent NSCLC who have already tried at least one prior treatment will receive the combination. The main goals are to check safety and see how well the drugs control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC STAGE IV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Kansas Cancer Center (KUCC)
NOT_YET_RECRUITINGFairway, Kansas, 66205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The University of Kansas Cancer Center, Westwood Campus
RECRUITINGKansas City, Kansas, 66205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••